Electra Therapeutics, Inc.

NAS:ETRAHealth Technologynasdaq_composite

$8.75+1.63%LiveIn session · ≈ AED 32.13 · Market cap —

Open-market trades from Form 4 filings

Insiders bought $40M and sold $0 in the filings shown.

Date	Name	Role	Type	Shares	Value
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	C-Conversion	1,087,934	—
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	P-Purchase	333,333	$5M
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	C-Conversion	2,002,310	—
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	C-Conversion	1,703,314	—
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	C-Conversion	758,279	—
Mon, 21 Sep 2026	OrbiMed Capital GP VII LLC	director, 10 percent owner	P-Purchase	1,000,000	$15M
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	C-Conversion	1,087,934	—
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	C-Conversion	758,279	—
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	C-Conversion	2,002,310	—
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	P-Purchase	1,000,000	$15M
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	C-Conversion	1,703,314	—
Mon, 21 Sep 2026	GORDON CARL L	director, 10 percent owner	P-Purchase	333,333	$5M
Mon, 21 Sep 2026	Stagliano Nancy	director	C-Conversion	255,635	—
Mon, 21 Sep 2026	Dong Quehuong (Kathy)	director, officer: President & CEO	C-Conversion	455,484	—
Mon, 21 Sep 2026	Koe Gary S.	officer: Chief Technical Officer	C-Conversion	63,656	—
Mon, 21 Sep 2026	Parry Graham	officer: Chief Scientific Officer	C-Conversion	85,504	—

From 13F filings

No institutional holdings are available.

Float 38,524,726 · outstanding 62,766,956